LIFTING: Heavy Lifting Strength Training in Head and Neck Cancer Survivors

Sponsor
University of Alberta (Other)
Overall Status
Recruiting
CT.gov ID
NCT04554667
Collaborator
(none)
15
1
1
20.2
0.7

Study Details

Study Description

Brief Summary

The LIFTING trial will examine the feasibility and safety of a heavy lifting strength training (HLST) program in head and neck cancer survivors (HNCS) at least 1 years post surgical neck dissection. The trial will determine whether this training style is safe and feasible in HNCS. Physical and psychosocial changes will also be reported.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise Intervention
Phase 1

Detailed Description

RATIONALE Despite improvements in treatments, HNCS still endure numerous acute and chronic side effects. Strength training has been shown to manage some of these side effects but most interventions have involved light-to-moderate resistance training programs. HLST may produce better outcomes but it is unknown if such a weight training program is feasible and safe for HNCS.

OBJECTIVE The primary aim of this proposed study is to examine the feasibility and safety of a HLST program in HNCS at least 1 year post-surgical neck dissection.

METHODS This single arm feasibility study will recruit 15-20 HNCS to complete the HLST program 2 times per week. The primary feasibility outcomes will include the eligibility rate (with reasons for ineligibility), recruitment rate (with reasons for refusal), 1 repetition maximum testing rate (with reasons for not completing the test), program adherence (including attendance, dose modifications, and progression), and follow-up assessment rate (with reasons for drop out). The primary efficacy outcome will be strength gains from baseline. Secondary efficacy outcomes will include physical functioning, quality of life, fear of cancer recurrence, pain, body composition, anxiety, fatigue, stress, shoulder mobility, self-esteem, sleep, and motivation to engage in a HLST program.

SIGNIFICANCE Weight training is an effective intervention in HNCS but the optimal weight training prescription is unknown. If heavy weight training is deemed safe and feasible in HNCS, it can be compared to light-to-moderate load weight training to determine if it is a better prescription for improving outcomes that are important to HNCS.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single arm, safety and feasibility trial.Single arm, safety and feasibility trial.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Feasibility and Safety of Heavy Lifting Strength Training in Head and Neck Cancer Survivors Post-Surgical Neck Dissection
Actual Study Start Date :
Nov 24, 2020
Anticipated Primary Completion Date :
Jul 31, 2022
Anticipated Study Completion Date :
Jul 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise Intervention

Single exercise arm

Behavioral: Exercise Intervention
Heavy Lifting Strength Training

Outcome Measures

Primary Outcome Measures

  1. Recruitment Rate [Over 12 weeks]

    Recruitment rate (with reasons for refusal). Recruitment minimum: 15 participants Recruitment maximum: 20 participants Higher number= better and more data

  2. Muscular Strength [Changes from baseline to 12 weeks]

    Change in muscular strength from baseline to postintervention with be assessed using maximal strength tests. Minimum: none Maximum: none Higher score= better strength

  3. Program Adherence [Over 12 weeks]

    Program adherence minimum: 80% Program adherence maximum: 100% Higher score= better adherence

Secondary Outcome Measures

  1. Physical functioning [Changes from baseline to 12 weeks]

    Assessed using the Neck Dissection Impairment Index (NDII) and maximum strength tests. Minimum: 40 Maximum: 100 Higher score= worse impairment

  2. Fear of cancer recurrence [Changes from baseline to 12 weeks]

    Assessed using the Fear of Cancer Recurrence Inventory (FCRI) Minimum: 0 Maximum: 36 Higher score= worse fear of cancer recurrence

  3. Post Traumatic Growth after cancer [Changes from baseline to 12 weeks]

    How cancer has changed an individual's life will be assessed using the Post Traumatic Growth Inventory (PTGI) Minimum: 0 Maximum: 105 Higher score= better (positive) post traumatic growth transformation

  4. Waist to hip ratio (body composition) [Changes from baseline to 12 weeks]

    Assessed using waist to hip ratio (WHR) measure. Minimum WHR: none Maximum WHR: none Higher score WHR= worse body composition

  5. Anxiety [Changes from baseline to 12 weeks]

    Assessed using the Spielberger State Trait Anxiety Inventory (STAI) Minimum: 20 Maximum: 80 Higher score= worse anxiety

  6. Fatigue [Changes from baseline to 12 weeks]

    Assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire Minimum: 0 Maximum: 52 Higher score=worse fatigue

  7. Stress [Changes from baseline to 12 weeks]

    Assessed using the Perceived Stress Scale (PSS) Minimum: 0 Maximum: 56 Higher score=worse perceived stress

  8. Shoulder Mobility [Changes from baseline to 12 weeks]

    Changes in shoulder mobility Minimum: 150 degrees (18-50 years); 130 degrees (over 50 years) Maximum: none Higher score= better mobility

  9. Self-Esteem [Changes from baseline to 12 weeks]

    Changes in level of self-esteem assessed using Rosenberg Self-Esteem (RSE) scale Minimum: 10 Maximum: 40 Higher score= better self-esteem

  10. Sleep [Changes from baseline to 12 weeks]

    Changes in sleep patterns assessed using the insomnia severity index (ISI) Minimum: 0 Maximum: 28 Higher score= worse insomnia

  11. Motivation [Changes from baseline to 12 weeks]

    Questions based on the theory of planned behaviour Minimum: 7 Maximum: 35 Higher score= better motivation

  12. Cancer specific quality of life [Changes from baseline to 12 weeks]

    Assessed using the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N Symptom Index) Minimum: 0 Maximum: 40 Higher score= worse head and neck cancer symptoms

  13. Cancer Symptom Burden [Changes from baseline to 12 weeks]

    Assessed using the revised Edmonton Symptom Assessment System (ESAS-r) Minimum: 0 Maximum: 100 Higher score= worse cancer symptoms

  14. Height [Changes from baseline to 12 weeks]

    Assessed using standing height without shoes. Minimum height: none Maximum height: none Taller: not specifically better or worse

  15. Weight [Changes from baseline to 12 weeks]

    Assessed using a digital scale without shoes. Minimum weight: none Maximum weight: none Higher weight: typically worse, but depends on other factors (ie. height, muscle mass, overall health status)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • previously diagnosed with any subtype and stage of head and neck cancer

  • at least one year post surgical neck dissection for head and neck cancer and showing full shoulder range of motion or recovery of the spinal accessory nerve

  • adults ages 18 and older

  • no unmanaged medical conditions, alcohol, and drug abuse

  • approved for a heavy lifting strength training program by the treating surgeon and a certified exercise physiologist

  • ability to understand and communicate in English

Exclusion Criteria:
  • having comorbidities or uncontrolled medical conditions that their referred clinicians indicate as inappropriate to participate in exercise

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alberta Edmonton Alberta Canada T6G 2H9

Sponsors and Collaborators

  • University of Alberta

Investigators

  • Principal Investigator: Kerry S Courneya, PhD, University of Alberta

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Alberta
ClinicalTrials.gov Identifier:
NCT04554667
Other Study ID Numbers:
  • 20-0169
First Posted:
Sep 18, 2020
Last Update Posted:
Apr 7, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Alberta
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2022